NO20041012L - Syntese av enantiomeriske rene amino-substituerte kodenserte bisykliske ringer - Google Patents
Syntese av enantiomeriske rene amino-substituerte kodenserte bisykliske ringerInfo
- Publication number
- NO20041012L NO20041012L NO20041012A NO20041012A NO20041012L NO 20041012 L NO20041012 L NO 20041012L NO 20041012 A NO20041012 A NO 20041012A NO 20041012 A NO20041012 A NO 20041012A NO 20041012 L NO20041012 L NO 20041012L
- Authority
- NO
- Norway
- Prior art keywords
- amino
- fused bicyclic
- substituted fused
- synthesis
- substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/04—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms
- C07D215/06—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to the ring carbon atoms having only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/40—Nitrogen atoms attached in position 8
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/04—Ortho- or peri-condensed ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/42—Benzopyrazines with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/79—Benzo [b] furans; Hydrogenated benzo [b] furans with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Furan Compounds (AREA)
- Quinoline Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US32320101P | 2001-09-12 | 2001-09-12 | |
| PCT/US2002/029372 WO2003022785A2 (en) | 2001-09-12 | 2002-09-12 | Synthesis of enantiomerically pure amino-substituted fused bicyclic rings |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20041012L true NO20041012L (no) | 2004-03-10 |
Family
ID=23258145
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20041012A NO20041012L (no) | 2001-09-12 | 2004-03-10 | Syntese av enantiomeriske rene amino-substituerte kodenserte bisykliske ringer |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US6825351B2 (es) |
| EP (1) | EP1487795B1 (es) |
| JP (1) | JP4431389B2 (es) |
| KR (1) | KR20040044909A (es) |
| CN (3) | CN101353324A (es) |
| AT (1) | ATE486850T1 (es) |
| BR (1) | BR0212443A (es) |
| CA (1) | CA2456614A1 (es) |
| DE (1) | DE60238218D1 (es) |
| HK (1) | HK1074044A1 (es) |
| HU (1) | HUP0600777A2 (es) |
| IL (2) | IL160115A0 (es) |
| MX (1) | MXPA04002356A (es) |
| NO (1) | NO20041012L (es) |
| NZ (1) | NZ531482A (es) |
| PL (1) | PL372705A1 (es) |
| RU (1) | RU2308451C2 (es) |
| WO (1) | WO2003022785A2 (es) |
| ZA (1) | ZA200400750B (es) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7354932B2 (en) | 2001-12-21 | 2008-04-08 | Anormed, Inc. | Chemokine receptor binding heterocyclic compounds with enhanced efficacy |
| WO2006052514A1 (en) * | 2004-11-04 | 2006-05-18 | Merck & Co., Inc. | Asymmetric hydrogenation of enamides |
| US7825088B2 (en) * | 2005-04-25 | 2010-11-02 | The Cbr Institute For Biomedical Research, Inc. | Methods for the treatment of multiple myeloma |
| US8569280B2 (en) * | 2005-04-25 | 2013-10-29 | Immune Disease Institute | Methods for the treatment of multiple myeloma |
| WO2007036036A1 (en) * | 2005-09-29 | 2007-04-05 | British Columbia Cancer Agency Branch | Method and composition for increasing the engraftment efficiency of stem cells |
| US20080155015A1 (en) * | 2006-12-20 | 2008-06-26 | Omx Technology Ab | Intelligent information dissemination |
| DE102008022221A1 (de) | 2008-05-06 | 2009-11-12 | Universität des Saarlandes | Inhibitoren der humanen Aldosteronsynthase CYP11B2 |
| EP2307334A1 (en) * | 2008-06-27 | 2011-04-13 | Merck Frosst Canada Ltd. | Synthesis of chiral amines |
| KR20100032496A (ko) * | 2008-09-18 | 2010-03-26 | 주식회사 이큐스팜 | 신규 5-(4-아미노페닐)-이소퀴놀린 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 Ｒａｆ 키나제의 과활성에 의해 유발되는 질환의 예방 또는 치료용 조성물 |
| US8541404B2 (en) | 2009-11-09 | 2013-09-24 | Elexopharm Gmbh | Inhibitors of the human aldosterone synthase CYP11B2 |
| PT2509619T (pt) | 2009-12-11 | 2021-03-11 | Medregen Llc | Métodos de tratamento utilizando mobilizadores de células estaminais e agentes imunossupressores |
| WO2011119738A2 (en) | 2010-03-23 | 2011-09-29 | The Johns Hopkins University | Methods of treatment using stem cell mobilizers |
| US9175321B2 (en) | 2011-10-26 | 2015-11-03 | Suzhou Tongli Biomedical Co., Ltd | R-praziquantel preparation method |
| FR2993561B1 (fr) * | 2012-07-17 | 2014-10-31 | Servier Lab | Procede de synthese enzymatique de la (7s)-1-(3,4-dimethoxy bicyclo[4.2.0]octa-1,3,5-triene 7-yl) n-methyl methanamine, et application a la synthese de l'ivabradine et de ses sels |
| HUE059749T2 (hu) | 2013-04-29 | 2022-12-28 | Medregen Llc | Sebgyógyítás autológ õssejt-mobilizáció útján |
| US9440899B2 (en) | 2014-12-15 | 2016-09-13 | Rohm And Haas Electronic Materials Llc | Purification method |
| JP6864296B2 (ja) | 2015-12-14 | 2021-04-28 | エックス４ ファーマシューティカルズ， インコーポレイテッド | がんを処置する方法 |
| WO2017106332A1 (en) | 2015-12-14 | 2017-06-22 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
| DK3393468T3 (da) | 2015-12-22 | 2022-12-19 | X4 Pharmaceuticals Inc | Fremgangsmåder til behandling af en immundefektsygdom |
| WO2017177230A1 (en) | 2016-04-08 | 2017-10-12 | X4 Pharmaceuticals, Inc. | Methods for treating cancer |
| EP3471727B1 (en) | 2016-06-21 | 2020-12-09 | X4 Pharmaceuticals, Inc. | Cxcr4 inhibitors and uses thereof |
| JP7084624B2 (ja) | 2016-06-21 | 2022-06-15 | エックス４ ファーマシューティカルズ， インコーポレイテッド | Ｃｘｃｒ４阻害剤およびその使用 |
| CN109641838A (zh) | 2016-06-21 | 2019-04-16 | X4 制药有限公司 | Cxcr4抑制剂及其用途 |
| US20190194122A1 (en) * | 2017-12-27 | 2019-06-27 | Apotex Inc. | Processes for the Preparation of Dasotraline and Intermediates Thereof |
| US10548889B1 (en) | 2018-08-31 | 2020-02-04 | X4 Pharmaceuticals, Inc. | Compositions of CXCR4 inhibitors and methods of preparation and use |
| EP3914599A4 (en) | 2019-01-23 | 2022-10-19 | The Johns Hopkins University | NON-IMMUNOSUPPRESSIVE ANALOGS OF FK506 AND ASSOCIATED USE |
| US20210008161A1 (en) | 2019-06-17 | 2021-01-14 | Crispr Therapeutics Ag | Methods and compositions for improved homology directed repair |
| EP4263829A1 (en) | 2020-12-17 | 2023-10-25 | Vertex Pharmaceuticals Incorporated | Compositions and methods for editing beta-globin for treatment of hemaglobinopathies |
| CN115872820A (zh) * | 2021-09-28 | 2023-03-31 | 中国科学院大连化学物理研究所 | 仿生催化不对称氢化合成手性2-官能团化四氢喹啉的方法 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA321A (en) | 1870-03-29 | C.A. Gregory | Improvements on apparatus for filling bottles, vials and other vessels and gauging their contents | |
| DE1207930B (de) * | 1956-02-03 | 1965-12-30 | Basf Ag | Verfahren zur Herstellung von Pyridin- bzw. Tetrahydrochinolinderivaten |
| GB9126677D0 (en) * | 1991-12-16 | 1992-02-12 | Johnson Matthey Plc | Improvements in chemical compounds |
| GB9200245D0 (en) * | 1992-01-07 | 1992-02-26 | British Bio Technology | Compounds |
| GB9400411D0 (en) * | 1994-01-11 | 1994-03-09 | Johnson Matthey Plc | Improvements in chemical compounds |
| GB9511357D0 (en) | 1995-06-06 | 1995-08-02 | Johnson Matthey Plc | Improved antiviral compounds |
| CA2249401A1 (en) * | 1996-03-22 | 1997-09-25 | The Dupont Merck Pharmaceutical Company | Novel asymmetric synthesis of r-.alpha.-propyl-piperonyl amine and its analogs |
| GB9726229D0 (en) | 1997-12-12 | 1998-02-11 | Zeneca Ltd | Resolution of chiral amines |
| KR20010032841A (ko) | 1997-12-19 | 2001-04-25 | 다케다 야쿠힌 고교 가부시키가이샤 | 아닐리드 유도체를 함유하는 ｃｃｒ5 길항용 약학 조성물 |
| US6365583B1 (en) | 1999-02-02 | 2002-04-02 | Anormed, Inc. | Methods to enhance white blood cell count |
| CZ20013421A3 (cs) * | 1999-03-24 | 2002-03-13 | Anormed Inc. | Heterocyklické sloučeniny váľící chemokinové receptory |
-
2002
- 2002-09-12 CN CNA2008101102755A patent/CN101353324A/zh active Pending
- 2002-09-12 JP JP2003526864A patent/JP4431389B2/ja not_active Expired - Lifetime
- 2002-09-12 IL IL16011502A patent/IL160115A0/xx unknown
- 2002-09-12 CN CNB02817593XA patent/CN1272322C/zh not_active Expired - Lifetime
- 2002-09-12 US US10/243,434 patent/US6825351B2/en not_active Expired - Lifetime
- 2002-09-12 BR BR0212443-2A patent/BR0212443A/pt not_active IP Right Cessation
- 2002-09-12 KR KR10-2004-7003699A patent/KR20040044909A/ko not_active Application Discontinuation
- 2002-09-12 WO PCT/US2002/029372 patent/WO2003022785A2/en active Search and Examination
- 2002-09-12 PL PL02372705A patent/PL372705A1/xx unknown
- 2002-09-12 MX MXPA04002356A patent/MXPA04002356A/es active IP Right Grant
- 2002-09-12 NZ NZ531482A patent/NZ531482A/en unknown
- 2002-09-12 CN CNB2006100054539A patent/CN100412062C/zh not_active Expired - Lifetime
- 2002-09-12 CA CA002456614A patent/CA2456614A1/en not_active Abandoned
- 2002-09-12 EP EP02775823A patent/EP1487795B1/en not_active Expired - Lifetime
- 2002-09-12 RU RU2004110928/04A patent/RU2308451C2/ru not_active IP Right Cessation
- 2002-09-12 HU HU0600777A patent/HUP0600777A2/hu unknown
- 2002-09-12 DE DE60238218T patent/DE60238218D1/de not_active Expired - Lifetime
- 2002-09-12 AT AT02775823T patent/ATE486850T1/de not_active IP Right Cessation
-
2004
- 2004-01-29 IL IL160115A patent/IL160115A/en unknown
- 2004-01-29 ZA ZA200400750A patent/ZA200400750B/en unknown
- 2004-03-10 NO NO20041012A patent/NO20041012L/no not_active Application Discontinuation
- 2004-10-06 US US10/959,823 patent/US7135570B2/en not_active Expired - Lifetime
-
2005
- 2005-06-22 HK HK05105214.4A patent/HK1074044A1/xx not_active IP Right Cessation
-
2006
- 2006-11-14 US US11/598,955 patent/US7452994B2/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IL160115A0 (en) | 2004-06-20 |
| EP1487795A2 (en) | 2004-12-22 |
| US20030114679A1 (en) | 2003-06-19 |
| ATE486850T1 (de) | 2010-11-15 |
| BR0212443A (pt) | 2005-03-15 |
| CA2456614A1 (en) | 2003-03-20 |
| JP4431389B2 (ja) | 2010-03-10 |
| CN100412062C (zh) | 2008-08-20 |
| US20070060757A1 (en) | 2007-03-15 |
| RU2308451C2 (ru) | 2007-10-20 |
| NZ531482A (en) | 2007-04-27 |
| US6825351B2 (en) | 2004-11-30 |
| US20050080267A1 (en) | 2005-04-14 |
| ZA200400750B (en) | 2005-04-06 |
| CN1272322C (zh) | 2006-08-30 |
| CN1608052A (zh) | 2005-04-20 |
| WO2003022785A2 (en) | 2003-03-20 |
| MXPA04002356A (es) | 2004-06-29 |
| CN1817864A (zh) | 2006-08-16 |
| CN101353324A (zh) | 2009-01-28 |
| HK1074044A1 (en) | 2005-10-28 |
| WO2003022785A3 (en) | 2004-09-30 |
| DE60238218D1 (de) | 2010-12-16 |
| US7452994B2 (en) | 2008-11-18 |
| EP1487795A4 (en) | 2005-02-09 |
| JP2005508316A (ja) | 2005-03-31 |
| IL160115A (en) | 2010-12-30 |
| RU2004110928A (ru) | 2005-10-10 |
| PL372705A1 (en) | 2005-07-25 |
| HUP0600777A2 (en) | 2007-01-29 |
| EP1487795B1 (en) | 2010-11-03 |
| KR20040044909A (ko) | 2004-05-31 |
| US7135570B2 (en) | 2006-11-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20041012L (no) | Syntese av enantiomeriske rene amino-substituerte kodenserte bisykliske ringer | |
| NZ765535A (en) | Enantiomeric separation of racemic nicotine by addition of an o,o’-disubstituted tartaric acid enantiomer | |
| HUP0400294A2 (hu) | Eljárás (S)-(+)- és (R)-(-)-10,11-dihidro-10-hidroxi-5H-dibenz/b,f/azepin-5-karboxamid előállítására | |
| DE60042035D1 (de) | Verfahren und zusammensetzungen zur herstellung von ophtalmischen linsen | |
| EA200400487A1 (ru) | Фармацевтическая композиция длительного высвобождения, содержащая метформин | |
| RU2007138100A (ru) | Дипиразолы в качестве средств для центральной нервной системы | |
| HUP0101322A2 (hu) | Eljárás ciklohexilidén-aminok cisz-szelektív katalitikus hidrogénezésére | |
| DE50115655D1 (de) | Verfahren zur herstellung von unsymmetrischen 4,6-bis(aryloxy)pyrimidin-derivaten | |
| BRPI0410619A (pt) | processo para a produção de um flange de conexão anular, e, flange de conexão anular | |
| ATE291006T1 (de) | Verfahren zur herstellung von salbutamolisomeren | |
| AR030938A1 (es) | Proceso de obtencion de los enantiomeros de la cetamina racemica; proceso de obtencion de sales farmaceuticamente aceptables de enantiomeros de la cetamina racemica y utilizacion de las sales farmaceuticamente aceptables obtenidas por el referido proceso | |
| HK1099759A1 (en) | A process for the resolution of nefopam | |
| ATE414781T1 (de) | Verbessertes verfahren zur herstellung des coenzyms q-10 | |
| ATE301127T1 (de) | Ferrocenylliganden und ein verfahren zur herstellung solcher liganden | |
| DE60003807D1 (de) | Enantiomere von mercaptolactonen und verfahren zu ihrer herstellung | |
| BRPI0407844A (pt) | processo para preparação de formas enancioméricas de derivados de 1,3-ciclohexanodiol com configuração cis | |
| ATE496038T1 (de) | Verfahren zur herstellung von quetiapin | |
| DE602004015310D1 (de) | Verfahren zur herstellung von mycophenolatmofetil | |
| ATE294789T1 (de) | Verfahren zur stereoselektiven herstellung von nitro-enamin-verbindungen | |
| NO20033944L (no) | Ny asymetrisk fremgangsmåte for fremstilling av diarylmetylpiperazinderivater og nye asymetriske diarylmetylaminer som mellomprodukter | |
| SE9801726D0 (sv) | New process | |
| ATE261931T1 (de) | Verfahren zur synthese alpha-substituierter ringsysteme | |
| DE602004006438D1 (de) | Verfahren zur herstellung von enantiomeren angereicherten aminosäuren | |
| ATE325111T1 (de) | Verfahren zur herstellung von 15-pentadecanolid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |